Skip to content

Thornton W. Sargent

5 papers in the library · 138 citations · publishing 1967-1989

Papers

Sort Most recent Most cited

Cerebral and peripheral demethylation of psychotomimetics measured by expired 14CO2.

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989 Thornton W. Sargent, U Braun, Gisela Braun et al. 2 citations

Demethylation of psychotomimetic compounds was measured by labeling each methyl and methoxy substitutent separately with 14C and injecting it into rats, intravenously and intracerebrally. Expired [14C]CO2 was measured continuously and the resultant multi-exponential curves yielded rates and integral demethylation. 5-Methoxy-N,N-dimethyltryptamine was not demethylated, eliminating one proposed...

Synthesis of 123I‐labelled 4‐iodo‐2, 5‐dimethoxyphenylisopropylamine

Journal of Labelled Compounds and Radiopharmaceuticals 1978 Gisela Braun, Alexander T. Shulgin, Thornton W. Sargent 9 citations

AbstractA rapid and convenient synthesis of the psychotomimetic agent 4‐iodo‐2, 5‐dimethoxyphenylisopropylamine is described, incorporating the radioisotope 123I (T1/2 13 hr). With the amine function of 2, 5‐dimethoxyphenylisopropylamine blocked as the phthalimide, it was found that the aromatic 4‐position could be directly iodinated with iodine monochloride. The phthalic acid moiety was...

Animal Pharmacology and Human Psychopharmacology of 3-Methoxy-4,5-Methylenedioxyphenylisopropylamine (MMDA)

Pharmacology 1973 Alexander T. Shulgin, Thornton W. Sargent, Carolina Lopez Naranjo 33 citations

A rationale is presented for the investigation of the synthesis and pharmacology of 3-methoxy-4,5-methylenedioxyphenyl isopropylamine (MMDA) as a potential psychodysleptic compound; these experiments are reported. The chemical synthesis and physical properties of this compound are described. The pharmacologic effects of MMDA in several animal species are presented, as are its clinical effects...

4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog.

Pharmacology 1971 Alexander T. Shulgin, Thornton W. Sargent, C. Naranjo

A new centrally active halo-amine, 4-bromo-2,5 dimethoxyphenylisopropylamine, is described. In clinical evalua tion it proved to enhance effectively both emotional and in tellectual perception, without the imagery and perceptual distortions commonly encountered with many of the chemically related psychotomimetics. These properties suggest a potential valuable role in conjunction with...

Leukocytes of Humans Exposed to Lysergic Acid Diethylamide: Lack of Chromosomal Damage

Science October 27, 1967 William D. Loughman, Thornton W. Sargent, David M. Israelstam 94 citations

Leukocyte cultures from eight human subjects who had had recent exposure to large doses of lysergic acid diethylamide were examined for chromosome abnormalities. The number of abnormalities was not significantly greater than that in control cultures.